Current and Future Trends in Anticonvulsant, Anxiety, and Stroke Therapy

Partial table of contents: ANTICONVULSANT THERAPY. Antiepileptic Drugs: Historical Perspective, Current Therapy, and Clinical Investigations (R. Porter). Mechanism-Based Approaches to Anticonvulsant Therapies: Modulation of Inhibitory and Excitatory Transmission (B. Meldrum). ANXIETY THERAPY. Antianxiety Agents: A Historical Perspective (M. Williams). Novel Anxiolytic Agents: Actions on Specific Subtypes of Central 5-HT Receptors (F. Yocca). Molecular Biological Insights into GABA and Benzodiazepine Receptor Structure (J. Tallman & H. Hutchison). STROKE THERAPY. Therapeutic Potential of NMDA Receptor Antagonists as Neuroprotective Agents (A. Foster, et al.). Brain Anti-Cytoxic Edema Agents (H. Kimelberg, et al.). NOVEL COMPOUNDS. Gepirone Hydrochloride: Preclinical Pharmacology and Recent Clinical Findings (J. Yevich, et al.). CGS 20625, a Novel Pyrazolopyridine with Selective Anxiolytic Activity (M. Jarvis, et al.). Therapeutic Effects of Anafranil in Obsessive Compulsive Disorder: Recent Clinical Findings. (R. Katz, et al.). Index.Meldrum, Brian S. is the author of 'Current and Future Trends in Anticonvulsant, Anxiety, and Stroke Therapy' with ISBN 9780471568698 and ISBN 0471568694.